Health Diagnostics and Imaging Stocks
Precision diagnostic providers and medical imaging manufacturers develop the critical infrastructure for disease detection, monitoring, and therapeutic guidance across human and veterinary medicine.
As of Oct 23, 2026, Health Diagnostics and Imaging has 105 US-listed companies worth $1.4T combined. The median member moved +0.0% over the past week; QGEN led among the 25 largest at +9.2% and DXCM trailed at -9.4%.
Companies in Health Diagnostics and Imaging
- TMO – Thermo Fisher Scientific Inc, $249B
- ABT – Abbott Laboratories, $177B
- DHR – Danaher Corporation, $162B
- SYK – Stryker Corporation, $118B
- MCK – McKesson Corporation, $117B
- NTRA – Natera Inc, $57.9B
- BDX – Becton Dickinson and Company, $54.6B
- A – Agilent Technologies Inc, $48.8B
- IDXX – IDEXX Laboratories Inc, $44.6B
- ZTS – Zoetis Inc, $33.9B
- GEHC – GE HealthCare Technologies Inc., $32.5B
- DXCM – DexCom Inc, $29.6B
- DGX – Quest Diagnostics Incorporated, $26.9B
- LH – Laboratory Corporation of America Holdings, $26.7B
- PHG – Koninklijke Philips NV ADR, $26.3B
- GH – Guardant Health Inc, $21.9B
- SNA – Snap-On Inc, $18.5B
- RVTY – Revvity Inc., $17.7B
- TEM – Tempus AI, Inc. Class A Common Stock, $12.3B
- TECH – Bio-Techne Corp, $11.4B
- ALGN – Align Technology Inc, $11B
- QGEN – Qiagen NV, $10.4B
- BIO – Bio-Rad Laboratories Inc, $9.6B
- CAI – Caris Life Sciences, Inc. Common Stock, $9B
- SHMXY – Shimadzu Corp, $7.6B
- LNTH – Lantheus Holdings Inc, $6.5B
- GRAL – GRAIL, LLC, $5.7B
- RDNT – RadNet Inc, $5.5B
- BLLN – BillionToOne, Inc. Class A Common Stock, $4.8B
- HTFL – Heartflow, Inc. Common Stock, $4.4B
- ICUI – ICU Medical Inc, $4B
- ADPT – Adaptive Biotechnologies Corp, $3.9B
- TLX – Telix Pharmaceuticals Limited, $3.8B
- VCYT – Veracyte Inc, $3.7B
- CDNA – CareDx Inc, $3.6B
- NEO – NeoGenomics Inc, $2.1B
- WGS – GeneDx Holdings Corp., $2B
- ALMR – Alamar Biosciences, Inc. Common Stock, $2B
- BFLY – Butterfly Network Inc, $1.8B
- PSNL – Personalis Inc, $1.7B
- ATEC – Alphatec Holdings Inc, $1.6B
- FRNM – Freenome, Inc. Common stock, $1.4B
- OPK – Opko Health Inc, $1.2B
- IRMD – Iradimed Co, $1.1B
- CSTL – Castle Biosciences Inc, $1.1B
- LMRI – Lumexa Imaging Holdings, Inc. Common Stock, $1B
- QDEL – Quidel Corporation, $885M
- VREX – Varex Imaging Corp, $784M
- FLGT – Fulgent Genetics Inc, $591M
- YDES – YD Bio Ltd, $477M
- MYGN – Myriad Genetics Inc, $396M
- PRE – Prenetics Global Ltd, $361M
- CV – CapsoVision, Inc. Common Stock, $361M
- ASPI – ASP Isotopes Inc. Common Stock, $315M
- BDSX – Biodesix Inc, $279M
- OSUR – OraSure Technologies Inc, $260M
- CATX – Perspective Therapeutics Inc., $259M
- NNNN – Anbio Biotechnology Class A Ordinary Shares, $205M
- XGN – Exagen Inc, $198M
- QTRX – Quanterix Corp, $163M
- BNR – Burning Rock Biotech Ltd, $158M
- LUCD – Lucid Diagnostics Inc, $116M
- IMDX – Insight Molecular Diagnostics Inc., $107M
- HYPR – Hyperfine Inc, $98.7M
- SERA – Sera Prognostics Inc, $80.5M
- LUNG – Pulmonx Corp, $77.3M
- MDXH – MDxHealth SA, $63M
- DXR – Daxor Corporation, $58.9M
- MDAI – Spectral AI Inc., $53.1M
- NNOX – Nano X Imaging Ltd, $42.3M
- QTI – QT Imaging Holdings, Inc. Common Stock, $39.2M
- PRPO – Precipio Inc, $38.9M
- ITOC – iTonic Holdings Ltd., $27.8M
- PAVM – PAVmed Inc, $18.3M
- HSCS – Heart Test Laboratories Inc. Common Stock, $16.5M
- CCM – Concord Medical Services Holdings, $16.2M
- AIFF – Firefly Neuroscience, Inc., $16M
- RADX – Radiopharm Theranostics Limited American Depositary Shares, $15.8M
- CNSY – Cerenome, Inc., $12.9M
- ADIL – Adial Pharmaceuticals Inc, $12.2M
- PLSM – Pulsenmore Ltd. Ordinary Shares, $11.8M
- ADVB – Advanced Biomed Inc. Common Stock, $10.5M
- HEPA – Hepion Pharmaceuticals Inc, $9.2M
- NDRA – ENDRA Life Sciences Inc, $9.1M
- BMRA – Biomerica Inc, $8.6M
- XWEL – XWELL Inc., $7.3M
- ACON – Aclarion Inc, $6.1M
- TRIB – Trinity Biotech plc, $5.5M
- VNRX – Volitionrx Ltd, $5.4M
- CDIO – Cardio Diagnostics Holdings Inc, $5.2M
- BIAF – bioAffinity Technologies, Inc., $4.8M
- CODX – Co-Diagnostics, Inc. Common Stock, $4.6M
- AMST – Amesite Operating Co, $4.1M
- NIKI – Niki BioSolutions, Inc., $3.7M
- GENE – Genetic Technologies Ltd, $3.7M
- AIDX – 20/20 Biolabs, Inc. Common Stock, $3.3M
- BJDX – Bluejay Diagnostics Inc, $3.3M
- ADTX – Aditxt Inc. , $3M
- POAS – Phaos Technology Holdings (Cayman) Limited, $2.7M
- ONCO – Onconetix Inc, $2.5M
- VRAX – Virax Biolabs Group Limited Ordinary Shares, $1.8M
- PRPH – ProPhase Labs Inc, $155,925
- TTOO – T2 Biosystms Inc, $19,631
- MOTS – Motus GI Holdings Inc, $1,277
- HLTH – Cue Health Inc